Metal Chelators and thiols in Endothelial Function and CVD

$468,329P01FY2010ATNIH

Oregon State University, Corvallis OR

Investigators

Linked publications & trials

Paper 32692358 Paper 27687220 Paper 26826269 Paper 26549877 Paper 25960613 Paper 24944020 Paper 24225134 Paper 23646980 Paper 23487751 Paper 23247967 Paper 23195686 Paper 23045003 Paper 22770994 Paper 22698272 Paper 22609537 Paper 22521877 Paper 22521482 Paper 22488161 Paper 22322067 Paper 22212472 Paper 22049228 Paper 22010221 Paper 21820513 Paper 21724870 Paper 21571063 Paper 21453670 Paper 21376114 Paper 21047085 Paper 20856100 Paper 20716298 Paper 20663894 Paper 20621033 Paper 20534165 Paper 20463304 Paper 20061611 Paper 19914377 Paper 19741195 Paper 19664690 Paper 19540342 Paper 19393377 Paper 19344250 Paper 19309264 Paper 19251588 Paper 19232511 Paper 19158425 Paper 19124074 Paper 18931933 Paper 18683239 Paper 18409172 Paper 18297110 Paper 18205546 Paper 18196984 Paper 18158360 Paper 17888947 Paper 17634371 Paper 17360480 Paper 17360415 Paper 17317208 Paper 17237348 Paper 17200124 Paper 17157175 Paper 17145551 Paper 17015830 Paper 16987811 Paper 16982030 Paper 16973969 Paper 16930126 Paper 16291234 Paper 16023898 Paper 15829111 Paper 15814196 Paper 15773903 Paper 15693022 Paper 15572176 Paper 15514305 Paper 15134511 Paper 14985508 Paper 14871476

Abstract

P01 AT002034 (Frei) 09/30/03-05/31/08 NIH/NCCAM Center of Excellence for Research on Complementary and Alternative Medicine Antioxidant Therapies (CERCAT) The major goals of this program project grant are to determine the roles of oxidative and nitrative stress in animal models of atherosclerosis, Lou Gehrig's disease, and aging, and the protective effects of lipoic acid and metal chelation therapy. The major goals of Project 1 (Metal Chelators and Thiols in Endothelial Function and CVD) are to understand the mechanisms by which thiol compounds and transition metals affect redoxsensitive cellular signaling and transcription factor activation;and to investigate in animal models of inflammation and atherosclerosis whether lipoic acid and metal chelators exert anti-inflammatory and antiatherosclerotic effects by inhibiting cellular adhesion molecule expression. Roles: Program Director, Project 1 Leader (Metal Chelators and Thiols in Endothelial Function and CVD), and Administrative Core Director

View original record on NIH RePORTER →